Over a dozen diabetes-focused research projects are currently underway under the Ministry of Science and Technology—largely through the Department of Biotechnology (DBT) and CSIR—as India steps up as a global hub for metabolic, genetic, and next-generation healthcare research, Union Minister Dr. Jitendra Singh said. Speaking at the inaugural ceremony of RSSDI 2026 in Bengaluru on November 20, 2026, he said the push toward molecular and genetic interventions taps into India’s vast population and genetic diversity to build solutions relevant at home and worldwide.
Dr. Singh noted that India’s biomedical ecosystem has shifted from relying on outside technologies to developing indigenous vaccines, antibiotics, gene therapies, biosimilars, and large-scale genomic resources such as the 10,000-individual India Genome Study across 84 population groups. He also pointed to vaccine pipelines for HPV, dengue, and malaria, alongside indigenous biosimilars like liraglutide and insulin Lispro, temperature-resilient insulin efforts, and startup work on oral insulin.
Among the key studies highlighted were an Indo-Danish project examining gut microbiota shifts in prediabetic and diabetic patients, genetically engineered E. coli Nissle 1917 and BRIC-THSTI work exploring GLP-1 delivery through gut bacteria, preconception-to-early-childhood metabolic studies, and the EINSTEIN study in rural Mysuru. Additional projects cover maternal nutrition’s intergenerational impact, exosomal and metabolomic biomarkers after gestational diabetes, fatty liver disease (MAFLD) pathways including S100A6, hepatic SIRT1 and insulin signalling, arachidonic acid’s effect on glucose and muscle preservation, and macrophage Gi signalling research published in September 2026.
Urging closer ties among government labs, private researchers, startups, clinicians, and medical bodies, the Minister called on the scientific community to push back against viral diet myths, unscientific claims, and unprescribed weight-loss drugs. With nearly 70 per cent of Indians under 40 ahead of the Viksit Bharat 2047 goal, he stressed that curbing youth obesity and diabetes is a shared national duty rather than a problem for doctors alone.
Karnataka Minister Krishna Byre Gowda and MP Dr. C. N. Manjunath joined the opening of the four-day Bengaluru conference (November 19–22), which also featured fellowships, awards, and book and guideline launches.


